SCI Pharmtech, Inc. engages in the research and development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and specialty chemicals. Its active pharmaceutical ingredients include Articaine HCl, Atomoxetine HCl, Bisoprolol Fumarate, Brinzolamide, Divalproex Sodium, Duloxetine HCl, Hydroxychloroquine sulfate, Loxoprofen Sodium, Methylphenidate HCl, Pentobarbital Sodium, Probucol, Propafenone HCl, Sodium Valproate, Thiopental, Valproic Acid, Adenine, Cannabidiol, and Dexmethylphenidate HCl. The company's intermediate products comprise Azetidin-3-ol hydrogenchloride, Diethyl Isobutyl Malonate, Diethyl dipropylmalonate, Diethyl ethyl(1-methylbutyl)malonate, Pyrogallolaldehyde, Benzhydrylamine, 1-Benzhydrylazetidin-3-ol, 1-(2-Hydroxyphenyl)-3-phenylpropan-1-one, N-Methyl-4-piperidinol, Ritalinic acid, d-Ritalinic acid HCl, (1R, 2S)-1 Phenyl-2-(pyrrolldin-1-yl)propan-1-ol HCl, and (1R, 2S)-1 Phenyl-2-(pyrrolldin-1-yl)propan-1-ol. Its intermediate products also consists of (S)-3-(methylmino)-1-(2-thi-enyl)propan-1-ol, (R)-3-(Methylamino)-1-phenylpropanol, (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol, Menthadienol, 5-pentylbenzene-1,3-diol Olivetol, Methyl 2,4-dihydroxy-6-pentylbenzoate, and Ethyl 2,4-dihydroxy-6-pentylbenzoate Ethyl Olivetolate. The company also provides custom manufacturing services. It sells its products in Italy, China, the United States, Germany, Taiwan, Switzerland, Spain, Japan, Netherlands, and internationally. The company was incorporated in 1987 and is based in Taoyuan City, Taiwan.
SCI Pharmtech Dividend Announcement
• SCI Pharmtech announced a annually dividend of NT$1.25 per ordinary share which will be made payable on 2024-08-05. Ex dividend date: 2024-07-01
• SCI Pharmtech annual dividend for 2024 was NT$1.25
• SCI Pharmtech annual dividend for 2023 was NT$0.28
• SCI Pharmtech's trailing twelve-month (TTM) dividend yield is 1.4%
• SCI Pharmtech's payout ratio for the trailing twelve months (TTM) is 17.22%
SCI Pharmtech Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-01 | NT$1.25 | annually | 2024-08-05 |
2023-07-27 | NT$0.28 | annually | 2023-09-01 |
2021-08-23 | NT$0.50 | annually | 2021-09-28 |
2020-07-13 | NT$4.83 | annually | 2020-08-18 |
2019-07-23 | NT$3.50 | annually | 2019-08-16 |
2018-07-31 | NT$1.79 | annually | 2018-08-17 |
2017-07-31 | NT$3.50 | annually | 2017-08-18 |
2016-07-29 | NT$3.20 | annually | |
2015-07-28 | NT$2.59 | annually | |
2014-08-05 | NT$1.50 | annually | |
2013-08-05 | NT$2.55 | annually | |
2012-07-18 | NT$1.51 | annually |
SCI Pharmtech Dividend per year
SCI Pharmtech Dividend growth
SCI Pharmtech Dividend Yield
SCI Pharmtech current trailing twelve-month (TTM) dividend yield is 1.4%. Interested in purchasing SCI Pharmtech stock? Use our calculator to estimate your expected dividend yield:
SCI Pharmtech Financial Ratios
SCI Pharmtech Dividend FAQ
Other factors to consider when evaluating SCI Pharmtech as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy SCI Pharmtech stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: SCI Pharmtech's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, SCI Pharmtech publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, SCI Pharmtech distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from SCI Pharmtech are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: SCI Pharmtech sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, SCI Pharmtech distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: SCI Pharmtech declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of SCI Pharmtech's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review SCI Pharmtech's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.